Epclusa is another hepatitis C direct-acting antiviral drug from the American company Gilead with sofosbuvir as the backbone. Patients with chronic hepatitis c must first undergo a systemic examination before taking Epclusa. Epclusa has little side effects but a high cure rate. Epclusa is used in combination with ribavirin, another antiviral drug, to treat advanced liver cirrhosis.
#health
You can check Epclusa cost- https://www.medixocentre.com/epclusa-cost
Like
Comment
Share
